Safe Rx LLC has entered into a distribution agreement with Jorgensen Labs, Inc., a leading specialty distributor to the animal health market. Under the agreement, Jorgensen will market and distribute Safe Rx™ locking prescription vials (LPVs) throughout North America and overseas.
"This agreement enables Safe Rx to access the animal health market immediately through a partner recognized industry-wide for their expertise," said Milton Cohen, President & CEO of Safe Rx.
"The veterinary community needs and wants to take an active role in battling the opioid epidemic. Safe Rx LPVs are a new and innovative tool that should be a part of every veterinary clinic's prescription services," said Norm Jorgensen, VP of Sales & Marketing at Jorgensen Labs. "It is an inexpensive and simple-to-use product that pet owners will readily value," he added.
Safe Rx™ LPVs are used by pharmacies and veterinary clinics in dispensing controlled substances and helping fight the drug abuse epidemics. In 2015, the Johns Hokpins University Bloomberg School of Public Health published an extensive opioid report recommending research into the effectiveness of more secure packaging, following the U.S. FDA's request for comment in 2013 on using innovative packaging solutions as a response to the prescription drug abuse epidemic.
Drug overdose is the leading cause of accidental death in the United States. Prescription drugs are the number one gateway to heroin addiction and have become the most commonly abused substances among 12 and 13-year-olds, with pilfering from family medicine cabinets the leading source for teen abuse.